v3.25.4
Consolidated Statements of Operations (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Restructuring $ 0 $ 174
Net loss from continuing operations (23,258) (29,537)
Net loss (22,499) (28,719)
Closing costs associated with sale of PWSH 1,012 0
Cost of revenue    
Stock-based compensation 421 585
Research and development    
Stock-based compensation $ 1,288 $ 1,222